Comparing the soluble urokinase-type plasminogen activator receptor (suPAR) levels between individuals with subjective cognitive decline and mild cognitive impairment

被引：0
|
作者：
Batun, G. Cetiner [1 ]
Gultekin, G. [1 ]
Yuruyen, M. [2 ]
Yavuzer, H. [3 ]
Armutcu, F. [4 ]
Emul, M. [1 ]
Kocabasoglu, N. [1 ]
机构：
[1] Istanbul Univ, Med Sch Cerrahpasa, Psychiat, Istanbul, Turkey
[2] Istanbul Univ, Med Sch Cerrahpasa, Dept Geriatr, Istanbul, Turkey
[3] Istanbul Univ, Med Sch Cerrahpasa, Geriatr, Istanbul, Turkey
[4] Istanbul Univ, Med Sch Cerrahpasa, Biochem, Istanbul, Turkey
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2016年 / 26卷
关键词：
CANCER;
D O I：
10.1016/S0924-977X(16)31734-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.5.a.004
引用
收藏
页码：S637 / S638
页数：2
相关论文
共 50 条
  • [31] Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients
    Jehn, Ulrich
    Schuette-Nuetgen, Katharina
    Henke, Ute
    Pavenstaedt, Hermann
    Suwelack, Barbara
    Reuter, Stefan
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [32] Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Patients With Acute Pancreatitis; Progress or 'suPAR' Revolution in Predicting Acute Pancreatitis Outcome
    Lipinski, Michal
    Rydzewska-Rosolowska, Alicja
    Rydzewski, Andrzej
    Rydzewska, Grazyna
    GASTROENTEROLOGY, 2015, 148 (04) : S679 - S679
  • [33] Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease
    Anis Ismail
    Salim S. Hayek
    Current Cardiology Reports, 2023, 25 : 1797 - 1810
  • [34] Soluble Urokinase-Type Plasminogen Activator Receptor in FSGS: Stirred but Not Shaken
    Reiser, Jochen
    Chapman, Harold
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (08): : 1611 - 1613
  • [35] Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease
    Ismail, Anis
    Hayek, Salim S.
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (12) : 1797 - 1810
  • [36] Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD
    Luo, Shengyuan
    Coresh, Josef
    Tin, Adrienne
    Rebholz, Casey M.
    Chen, Teresa K.
    Hayek, Salim S.
    Tracy, Melissa
    Lipkowitz, Michael S.
    Appel, Lawrence J.
    Levey, Andrew S.
    Inker, Lesley A.
    Reiser, Jochen
    Grams, Morgan Erika
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (07): : 1013 - 1021
  • [37] A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
    Spinale, Joann M.
    Mariani, Laura H.
    Kapoor, Shiv
    Zhang, Jidong
    Weyant, Robert
    Song, Peter X.
    Wong, Hetty N.
    Troost, Jonathan P.
    Gadegbeku, Crystal A.
    Gipson, Debbie S.
    Kretzler, Matthias
    Nihalani, Deepak
    Holzman, Lawrence B.
    KIDNEY INTERNATIONAL, 2015, 87 (03) : 564 - 574
  • [38] Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus
    Toldi, Gergely
    Szalay, Balazs
    Beko, Gabriella
    Bocskai, Marta
    Deak, Magdolna
    Kovacs, Laszlo
    Vasarhelyi, Barna
    Balog, Attila
    BIOMARKERS, 2012, 17 (08) : 758 - 763
  • [39] Evaluation of plasma soluble urokinase plasminogen activator receptor (SuPAR) levels in ulcerative colitis
    Yilmaz, Huriye Erbak
    Aksun, Saliha
    Gunay, Sueleyman
    Elmali, Ferhan
    Cekic, Cem
    ARAB JOURNAL OF GASTROENTEROLOGY, 2023, 24 (03) : 175 - 179
  • [40] The levels of soluble urokinase plasminogen activator receptor (suPAR) in saliva are influenced by acute stress
    Fernandez-Botran, Rafael
    Szabo, Yvette Z.
    Lyle, Keith B.
    Newton, Tamara L.
    BIOLOGICAL PSYCHOLOGY, 2021, 165
12345